DONATE TODAY
To Increase Patient Access
SHOW POST CATEGORIESSHOW ALL POSTS

Post Category: Cover Tip

March 27, 2023
What Are Decentralized Clinical Trials, eConsent, How to Access and Can They Help YOU?

In decentralized Clinical Trials some or all trial-related procedures and compiling of patient and trial data takes place at locations/sites that are remote from the Principal Investigator.

Read More
February 15, 2023
DISEASE EDUCATION & CALLING ALL HEALTH AND INCREASED PATIENT ACCESS INVESTORS

This Month, I’d like to introduce you to the company, Reglagene, www.reglagene.com, a therapeutics company located in Tucson, AZ transforming tubulin targeting therapy for CNS diseases.

Read More
February 13, 2023
DISEASE EDUCATION: What is Proton Therapy?

An advanced and highly precise form of radiation treatment is known as Proton Therapy (PT). PT minimizes damage to the surrounding tissue and risk of short- and long-term side effects because it allows radiation specialists to focus radiation directly into the tumor.

Read More
February 6, 2023
Advances in Precision Medicine, NGS Testing, and Breaking the Barriers with Clinical Trials

Targeted therapies are a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. They are the foundation of precision medicine. May12, 2023

Read More
December 3, 2022
"20 Years of Increasing Patient ACCESS” to Specialists, Advanced Treatment Options, INCLUDING Treatments that are Standard of Care or FDA Approved that Patients are NOT Offered, Diagnostics and Clinical Trials

The End Brain Cancer Initiative (EBCI) and I are once again thrilled to have this platform to increase patient education, awareness & outreach to the global brain tumor community and to the general public with the goal of increasing their direct access to top brain tumor specialists at brain tumor centers of excellence, multiple treatment options/diagnostics and clinical trials.

Read More
October 5, 2022
ADVOCACY & DISEASE EDUCATION: PDUFA

Today, I’ve got my “Advocacy” hat on and am writing about PDUFA as it is a vital piece of legislation that all of us need to know about and to advocate for to ensure that PDUFA remains in effect. As many of you know, in June of 2002, my late husband, Christopher Stewart Elliott, lost […]

Read More
October 3, 2022
INCREASING PATIENT DISEASE EDUCATION, AWARENESS & OUTREACH FOR GREATER ACCESS TO ADVANCED DIAGNOSTICS, SPECIALISTS AND TREATMENT OPTIONS/CLINICAL TRIALS WITH ENDEAVOR BIOMEDICINES

If you have a solid tumor, you may benefit from an additional test called Next Generation Sequencing (NGS), which looks at the genes associated with cancer.

Read More
August 1, 2022
CALL TO ACTION:
INCREASE CAPACITY & SUSTAINABILITY

To create increased impact in the health and research industries and to help us reach our goal of growing to a $2M 501 (c)3 non-profit social enterprise organization, we are expanding our board of directors and are seeking new members.

Read More
August 1, 2022
DISEASE EDUCATION: The End Brain Cancer Initiative (EBCI) this month is sharing with you information related to a very rare disease that only affects @ 1,500 people in the U.S. annually. This disease is known as PCNS

PROSPECT is an open-label, Phase II study evaluating the efficacy, safety, and pharmacokinetics of an investigational oral medicine called Tirabrutinib (ONO-4059), for patients with primary central nervous system lymphoma (PCNSL).

Read More
July 6, 2022
DISEASE EDUCATION: End Brain Cancer Initiative’s “2022 Know All Your Brain Cancer Treatment Options Meeting/Event” Specialist Presentations

May is National Brain Tumor/Brain Cancer Awareness Month. Each May, the www.EndBrainCancer.org (EBCI) brings together brain cancer specialists, patients, caregivers, families, industry, advocates, etc. to discuss and learn about treatments and clinical trials.

Read More
May 7, 2022
ADVANCED MRI APPLICATIONS FOR RECURRENT GLIOBLASTOMA BRAIN TUMORS & A NEW PHASE 1 CLINICAL TRIAL

Imaging Biometrics (IB) has been developing imaging analysis software for primary brain tumors for close to 30 years. Recently, their imaging software was used to assess treatment response in a pre-clinical study of Gallium Maltolate.

Read More
March 11, 2022
CELEBRATING 20 YEARS: End Brain Cancer Initiative Seeking ACTIVE Board Members and Large Donors to Help Us Move from a Board of Staff to a Board of Governors for Increased Impact

Mission: to enhance cancer patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, neuro-surgeons, advanced & innovative treatments, and clinical trials.

Read More

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
Our Case For Change
EBCI In The News
Patient Support Services
Patient Resource Center
VOLUNTEER WITH EBCI
GET IN TOUCH
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram